4//SEC Filing
Mallick Parag 4
Accession 0001808805-25-000049
CIK 0001808805other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 7:19 PM ET
Size
6.9 KB
Accession
0001808805-25-000049
Insider Transaction Report
Form 4
Mallick Parag
DirectorChief Scientist10% Owner
Transactions
- Purchase
Common Stock
2025-05-08$0.73/sh+12,000$8,788→ 20,491,892 total - Purchase
Common Stock
2025-05-12$0.73/sh+1,500$1,098→ 20,493,392 total
Footnotes (2)
- [F1]Represents the weighted average share price of an aggregate total of 12,000 shares purchased in the price range of $0.7058 to $0.7520 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Represents the weighted average share price of an aggregate total of 1,500 shares purchased in the price range of $0.7229 to $0.7334 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Documents
Issuer
Nautilus Biotechnology, Inc.
CIK 0001808805
Entity typeother
Related Parties
1- filerCIK 0001857948
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 7:19 PM ET
- Size
- 6.9 KB